Does mycophenolate mofetil increase the incidence of cytomegalovirus disease compared with azathioprine after cadaveric kidney transplantation?

Transplantation Proceedings

Volumn 37, Issue 2, 2005, Pages 850-851

  Basic Jukic, N ^a   Kes, P ^a   Bubic Filipi, L J ^a   Puretic, Z ^a   Brunetta, B ^a   Pasini, J ^a  

^a KBC Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DATA BASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTE;

EID: 17844404571     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.12.228     Document Type: Conference Paper

References (8)

1. European Mycophenolate Mofetil Cooperative Study Group Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection Lancet 345 1995 1321
2. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric kidney transplantation Transplantation 61 1996 1029
3. H.W. Sollinger, S. Cho, G. Danovich Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients Transplantation 60 1995 225
4. C.G. ter Meulen, J.F.M. Wetzels, L.B. Hilbrands The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation Nephrol Dial Transplant 15 2000 711
5. J.M. Sarmiento, S.R. Munn, C.V. Paya Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation? Clin Transplant 12 1998 371
6. J. Sarmiento, D. Dockrell, T. Schwab Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients Clin Transplant 14 2000 136
7. M.A. Munoz, A. Andres, R. Gallego Mycophenolate mofetil immunosuppressive therapies increase the incidence of cytomegalovirus infection in renal transplantation Transplant Proc 34 2002 97
8. M. Giral, J.M. Nguyen, P. Daguin Mycophenolate mofetil does not modify the incidence of cytomegalovirus (CMV) disease after kidney transplantation but prevents CMV-induced chronic graft dysfunction J Am Soc Nephrol 12 2001 1758